Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma-Reference-Cited by-同舟云学术

Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma

Published:2024-03-07 Issue:4 Volume:40 Page:647-655
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Cordeiro M. Francesca¹²,Denis Philippe³,Astarita Carlo⁴,Belsey Jonathan⁵,Rivas Marcos⁶,García-Feijoo Julián⁷

Affiliation:

1. Imperial College Ophthalmic Research Group (ICORG), Imperial College London, London, UK

2. Glaucoma & Retinal Neurodegeneration Research Group, Institute of Ophthalmology, University College London, London, UK

3. Service d’Ophtalmologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France

4. AbbVie S.r.l, Campoverde, Italy

5. JB Medical, London, UK

6. AbbVie, Madrid, Spain

7. Department of Ophthalmology, San Carlos Clinical Hospital, UCM, Instituto de Investigaciones Oftalmologicas Ramon Castroviejo, Madrid, Spain

Funder

AbbVie

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2322048

Reference52 articles.

1. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study

2. The number of people with glaucoma worldwide in 2010 and 2020

3. Secondary glaucomas: the tasks ahead;Krishnadas R;Community Eye Health,2001

4. The Ocular Hypertension Treatment Study

5. Risk Factors Associated with the Incidence of Open-Angle Glaucoma: The Visual Impairment Project